Efficacy and Safety Study of MP-513 in Patients With Type 2 Diabetes
Clinical trial NCT00628212 · COMPLETED
Trial details
- NCT number
- NCT00628212
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2008-12-01
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.